VIADERM Trademark

Trademark Overview

On Friday, September 18, 2020, a trademark application was filed for VIADERM with the United States Patent and Trademark Office. The USPTO has given the VIADERM trademark a serial number of 90191770. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 3, 2024. This trademark is owned by Vivex Biologics Group, Inc.. The VIADERM trademark is filed in the Pharmaceutical Products category with the following description:

Biological amniotic tissue intended for subsequent implantation
viaderm

General Information

Serial Number90191770
Word MarkVIADERM
Filing DateFriday, September 18, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesBiological amniotic tissue intended for subsequent implantation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 27, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVivex Biologics Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameVivex Biologics Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Trademark Events

Event DateEvent Description
Tuesday, September 22, 2020NEW APPLICATION ENTERED
Wednesday, January 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 25, 2021SOU EXTENSION 1 FILED
Monday, October 25, 2021SOU TEAS EXTENSION RECEIVED
Monday, October 25, 2021SOU EXTENSION 1 GRANTED
Wednesday, October 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 26, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 26, 2022SOU EXTENSION 2 FILED
Tuesday, April 26, 2022SOU EXTENSION 2 GRANTED
Thursday, April 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU EXTENSION 3 FILED
Monday, October 17, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 17, 2022SOU EXTENSION 3 GRANTED
Wednesday, October 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2023SOU EXTENSION 4 FILED
Wednesday, May 3, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, June 15, 2023SOU EXTENSION 4 GRANTED
Tuesday, October 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 3, 2023SOU EXTENSION 5 FILED
Wednesday, May 3, 2023PETITION TO REVIVE-GRANTED
Wednesday, May 3, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, May 4, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, June 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 5, 2023SOU EXTENSION 5 GRANTED
Monday, June 3, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, October 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

viaderm subsequent implantation intended tissue amniotic biological